Understanding the efficacy and tolerability of migraine treatment: a deep dive into CGRP antagonists

Introduction The discovery of the role of the calcitonin gene-related peptide (CGPR) in migraine pathogenesis ushered in a new era in headache medicine. This evidence led to the development of small molecule CGRP receptor antagonists and monoclonal antibodies targeting either CGRP or its receptor.